Low prediagnostic levels of circulating adiponectin were associated with an increased risk of pancreatic cancer, according to a study published in the Journal of the National Cancer Institute. In order to determine if prediagnostic plasma levels of adiponectin were linked to an increased risk of pancreatic cancer, Ying Bao, M.D., Sc.D., Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and colleagues, pooled the data from five prospective U.S. cohort studies, and matched 468 pancreatic cancer case subjects with 1,080 healthy control subjects by cohort, year of birth, smoking status, fasting status, and month of blood draw. Read more here.
Study mentioned: Zhang J, Hochwald SN. Plasma Adiponectin: A Possible Link Between Fat Metabolism and Pancreatic Cancer Risk. J Natl Cancer Inst. 2012 Dec 14. [Epub ahead of print] PMID: 23243204
No comments:
Post a Comment